Baird Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.3M | Buy |
|
|||||
|
2025
Q1 | $7.76M | Sell |
|
|||||
|
2024
Q4 | $6.59M | Sell |
|
|||||
|
2024
Q3 | $10.8M | Sell |
|
|||||
|
2024
Q2 | $25.2M | Sell |
|
|||||
|
2024
Q1 | $23.4M | Sell |
|
|||||
|
2023
Q4 | $27.7M | Buy |
|
|||||
|
2023
Q3 | $22.8M | Buy |
|
|||||
|
2023
Q2 | $22.1M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Sell |
|
|||||
|
2022
Q4 | $17.4M | Buy |
|
|||||
|
2022
Q3 | $16.3M | Buy |
|
|||||
|
2022
Q2 | $15.6M | Sell |
|
|||||
|
2022
Q1 | $16.1M | Sell |
|
|||||
|
2021
Q4 | $16.7M | Buy |
|
|||||
|
2021
Q3 | $13.5M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $11.9M | Buy |
|
|||||
|
2020
Q4 | $12.3M | Buy |
|
|||||
|
2020
Q3 | $11.3M | Buy |
|
|||||
|
2020
Q2 | $10.1M | Sell |
|
|||||
|
2020
Q1 | $9.92M | Sell |
|
|||||
|
2019
Q4 | $9.94M | Buy |
|
|||||
|
2019
Q3 | $5.65M | Buy |
|
|||||
|
2019
Q2 | $5.84M | Buy |
|
|||||
|
2019
Q1 | $4.91M | Buy |
|
|||||
|
2018
Q4 | $3.46M | Buy |
|
|||||
|
2018
Q3 | $758K | Sell |
|
|||||
|
2018
Q2 | $890K | Buy |
|
|||||
|
2018
Q1 | $813K | Buy |
|
|||||
|
2017
Q4 | $612K | Buy |
|
|||||
|
2017
Q3 | $419K | Buy |
|
|||||
|
2017
Q2 | $342K | Buy |
|
|||||
|
2017
Q1 | $231K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.94M | Buy |
|
|||||
|
2015
Q4 | $1.05M | Buy |
|
|||||
|
2015
Q3 | $743K | Sell |
|
|||||
|
2015
Q2 | $892K | Buy |
|